Home NDC 53002-1687 LYZA
Product NDC 53002-1687
11-digit product format 530021687
Labeler code 53002
Product ID 53002-1687_92b408ff-5374-451f-94d2-5ee8b63718b2
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name norethindrone
Dosage form TABLET
Route ORAL
Labeler RPK Pharmaceuticals, Inc.
Application ANDA200980
Marketing category ANDA
Marketing start 2013-06-24
Marketing end 0000-00-00
Substance NORETHINDRONE
Active strength 0 mg/1
Pharmacologic classes Progesterone Congeners [CS],Progestin [EPC]
NDC exclude flag No
Listing certified through 2021-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 56 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 53002-1687-3 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 53002-1687-1 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 53002-1687-6 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 53002-1687-3 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 53002-1687-1 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 53002-1687-6 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 53002-1687-3 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 53002-1687-1 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 53002-1687-6 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 53002-1687-3 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 53002-1687-1 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 53002-1687-6 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 53002-1687-3 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 53002-1687-1 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 53002-1687-6 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 53002-1687-3 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 53002-1687-1 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 53002-1687-6 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product D Discontinued by firm 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 53002-1687-3 D Discontinued by firm 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 53002-1687-1 D Discontinued by firm 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 53002-1687-6 D Discontinued by firm 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 53002-1687-3 D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 53002-1687-1 D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 53002-1687-6 D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 53002-1687-3 D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 53002-1687-1 D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 53002-1687-6 D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 53002-1687-3 D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 53002-1687-1 D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 53002-1687-6 D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 53002-1687-3 D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 53002-1687-1 D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 53002-1687-6 D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 53002-1687-3 D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 53002-1687-1 D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 53002-1687-6 D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2020-12-18 03:04 UTC · source 2020-12-17 excluded product product I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-12-18 03:04 UTC · source 2020-12-17 excluded package package 53002-1687-6 I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-12-18 03:04 UTC · source 2020-12-17 excluded package package 53002-1687-1 I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-12-18 03:04 UTC · source 2020-12-17 excluded package package 53002-1687-3 I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-06-10 20:45 UTC · source 2020-06-10 excluded product product I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2020-06-10 20:45 UTC · source 2020-06-10 excluded package package 53002-1687-6 I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2020-06-10 20:45 UTC · source 2020-06-10 excluded package package 53002-1687-3 I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2020-06-10 20:45 UTC · source 2020-06-10 excluded package package 53002-1687-1 I Inactivated by FDA 9bebd1f3094a…5416666fcb17…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A200980-001 NORETHINDRONE NORETHINDRONE 0.35MG TABLET / ORAL-28 AB2 RS 2013-06-12
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A200980-001 AB2
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 41 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A200980-001 NORETHINDRONE 0.35MG TABLET / ORAL-28 AB2 RS 2013-06-12 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A200980-001 NORETHINDRONE 0.35MG TABLET / ORAL-28 AB2 RS 2013-06-12 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A200980-001 NORETHINDRONE 0.35MG TABLET / ORAL-28 AB2 RS 2013-06-12 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A200980-001 NORETHINDRONE 0.35MG TABLET / ORAL-28 AB2 RS 2013-06-12 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A200980-001 NORETHINDRONE 0.35MG TABLET / ORAL-28 AB2 RS 2013-06-12 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A200980-001 NORETHINDRONE 0.35MG TABLET / ORAL-28 AB2 RS 2013-06-12 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A200980-001 NORETHINDRONE 0.35MG TABLET / ORAL-28 AB2 RS 2013-06-12 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A200980-001 NORETHINDRONE 0.35MG TABLET / ORAL-28 AB2 RS 2013-06-12 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A200980-001 NORETHINDRONE 0.35MG TABLET / ORAL-28 AB2 RS 2013-06-12 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A200980-001 NORETHINDRONE 0.35MG TABLET / ORAL-28 AB2 RS 2013-06-12 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A200980-001 NORETHINDRONE 0.35MG TABLET / ORAL-28 AB2 RS 2013-06-12 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A200980-001 NORETHINDRONE 0.35MG TABLET / ORAL-28 AB2 RS 2013-06-12 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A200980-001 NORETHINDRONE 0.35MG TABLET / ORAL-28 AB2 RS 2013-06-12 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A200980-001 NORETHINDRONE 0.35MG TABLET / ORAL-28 AB2 RS 2013-06-12 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A200980-001 NORETHINDRONE 0.35MG TABLET / ORAL-28 AB2 RS 2013-06-12 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A200980-001 NORETHINDRONE 0.35MG TABLET / ORAL-28 AB2 RS 2013-06-12 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A200980-001 NORETHINDRONE 0.35MG TABLET / ORAL-28 AB2 RS 2013-06-12 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A200980-001 NORETHINDRONE 0.35MG TABLET / ORAL-28 AB2 RS 2013-06-12 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A200980-001 NORETHINDRONE 0.35MG TABLET / ORAL-28 AB2 RS 2013-06-12 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A200980-001 NORETHINDRONE 0.35MG TABLET / ORAL-28 AB2 RS 2013-06-12 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A200980-001 NORETHINDRONE 0.35MG TABLET / ORAL-28 AB2 RS 2013-06-12 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A200980-001 NORETHINDRONE 0.35MG TABLET / ORAL-28 AB2 RS 2013-06-12 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A200980-001 NORETHINDRONE 0.35MG TABLET / ORAL-28 AB2 RS 2013-06-12 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A200980-001 NORETHINDRONE 0.35MG TABLET / ORAL-28 AB2 RS 2013-06-12 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 A200980-001 NORETHINDRONE 0.35MG TABLET / ORAL-28 AB2 RS 2013-06-12 3f01610625f2…2019-09-15 20:21 UTC 2019-09 A200980-001 NORETHINDRONE 0.35MG TABLET / ORAL-28 AB2 RS 2013-06-12 b00525d2431f…2019-07-19 19:46 UTC 2019-07 A200980-001 NORETHINDRONE 0.35MG TABLET / ORAL-28 AB2 RS 2013-06-12 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A200980-001 NORETHINDRONE 0.35MG TABLET / ORAL-28 AB2 RS 2013-06-12 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A200980-001 NORETHINDRONE 0.35MG TABLET / ORAL-28 AB2 RS 2013-06-12 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A200980-001 NORETHINDRONE 0.35MG TABLET / ORAL-28 AB2 RS 2013-06-12 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A200980-001 NORETHINDRONE 0.35MG TABLET / ORAL-28 AB2 RS 2013-06-12 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A200980-001 NORETHINDRONE 0.35MG TABLET / ORAL-28 AB2 RS 2013-06-12 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A200980-001 NORETHINDRONE 0.35MG TABLET / ORAL-28 AB2 RS 2013-06-12 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A200980-001 NORETHINDRONE 0.35MG TABLET / ORAL-28 AB2 RS 2013-06-12 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A200980-001 NORETHINDRONE 0.35MG TABLET / ORAL-28 AB2 RS 2013-06-12 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A200980-001 NORETHINDRONE 0.35MG TABLET / ORAL-28 AB2 RS 2013-06-12 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A200980-001 NORETHINDRONE 0.35MG TABLET / ORAL-28 AB2 RS 2013-06-12 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A200980-001 NORETHINDRONE 0.35MG TABLET / ORAL-28 AB2 RS 2013-06-12 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A200980-001 NORETHINDRONE 0.35MG TABLET / ORAL-28 AB2 RS 2013-06-12 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A200980-001 NORETHINDRONE 0.35MG TABLET / ORAL-28 AB2 RS 2013-06-12 cb3db0bc1861…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 41 observed states.
FDA-Initiated Inactive NDC Indexing# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join MELEYA NORETHINDRONE Xiromed LLC 534c5717-382c-4109-3208-e21b32e4c4c9 2025-03-06 Warnings, Adverse reactions Exact identifier application applno (ANDA): 200980 application number: ANDA200980